Jiachun Su

6PUBLICATIONS
29CO-AUTHORS
Molecular targetsNanoscale characterisationPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 22, 2026
NSUN6 deficiency drives immune suppression in pancreatic cancer via the KDM5A-CCL2-macrophage axis.

Lingxing Zeng, Shuang Liu, Xinyi Peng

|Nov 13, 2023
Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma.

Rui Li, Hongzhe Zhao, Xudong Huang

|Oct 10, 2023
CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes.

Yanfen Zheng, Xingyang Li, Shuang Deng

|Jun 16, 2023
N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer.

Jiachun Su, Rui Li, Ziming Chen

|Sep 07, 2022
RNA m6A regulates transcription via DNA demethylation and chromatin accessibility.

Shuang Deng, Jialiang Zhang, Jiachun Su

|Aug 04, 2021
NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization.

Jiachun Su, Guandi Wu, Ying Ye

Pageof 1

Frequent Collaborators

6 joint publications

Lingxing Zeng

5 joint publications

Jian Zheng

4 joint publications

Zhixiang Zuo

3 joint publications

Jialiang Zhang